However, Novo Nordisk, Ozempics manufacturer, released results from two clinical trials in November 2025 that showed that taking an oral GLP-1 didnt slow disease progression among people with Alzheimers compared to those who took a placebo
"Importantly, our findings do not prove that SNAC causes harm in humans," Dr
Visibly reduces pigmentation spots, blemish marks and uneven tone
These results established dose-response efficacy for mazdutide in an Asian population and supported the selection of 4 mg and 6 mg doses for Phase 3 evaluation in the GLORY program
GLP-1 Drugs: What Employers Need to Know April 28, 2025 GLP-1 drugs like Ozempic and Zepbound have gained significant attention in recent years for their effectiveness in treating both diabetes and assisting with weight loss
Your doctor can help you decide if tirzepatide is right for you and can prescribe it to you if it is